156 related articles for article (PubMed ID: 23749114)
1. Enhanced inhibition of bladder cancer cell growth by simultaneous knockdown of antiapoptotic Bcl-xL and survivin in combination with chemotherapy.
Kunze D; Erdmann K; Froehner M; Wirth MP; Fuessel S
Int J Mol Sci; 2013 Jun; 14(6):12297-312. PubMed ID: 23749114
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells.
Kunze D; Kraemer K; Erdmann K; Froehner M; Wirth MP; Fuessel S
Int J Oncol; 2012 Oct; 41(4):1271-7. PubMed ID: 22797576
[TBL] [Abstract][Full Text] [Related]
3. siRNA-mediated inhibition of antiapoptotic genes enhances chemotherapy efficacy in bladder cancer cells.
Kunze D; Erdmann K; Froehner M; Wirth MP; Fuessel S
Anticancer Res; 2012 Oct; 32(10):4313-8. PubMed ID: 23060552
[TBL] [Abstract][Full Text] [Related]
4. Antisense- and siRNA-mediated inhibition of the anti-apoptotic gene Bcl-xL for chemosensitization of bladder cancer cells.
Rieger C; Huebner D; Temme A; Wirth MP; Fuessel S
Int J Oncol; 2015 Sep; 47(3):1121-30. PubMed ID: 26201840
[TBL] [Abstract][Full Text] [Related]
5. Multitarget siRNA inhibition of antiapoptotic genes (XIAP, BCL2, BCL-X(L)) in bladder cancer cells.
Kunze D; Wuttig D; Fuessel S; Kraemer K; Kotzsch M; Meye A; Grimm MO; Hakenberg OW; Wirth MP
Anticancer Res; 2008; 28(4B):2259-63. PubMed ID: 18751404
[TBL] [Abstract][Full Text] [Related]
6. The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines.
Glienke W; Maute L; Wicht J; Bergmann L
Tumour Biol; 2012 Jun; 33(3):757-65. PubMed ID: 22170433
[TBL] [Abstract][Full Text] [Related]
7. siRNA-mediated inhibition of survivin gene enhances the anti-cancer effect of etoposide in U-937 acute myeloid leukemia cells.
Jafarlou M; Baradaran B; Shanehbandi D; Saedi TA; Jafarlou V; Ismail P; Othman F
Cell Mol Biol (Noisy-le-grand); 2016 May; 62(6):44-9. PubMed ID: 27262801
[TBL] [Abstract][Full Text] [Related]
8. siRNA-mediated Bcl-2 and Bcl-xl gene silencing sensitizes human hepatoblastoma cells to chemotherapeutic drugs.
Lei XY; Zhong M; Feng LF; Zhu BY; Tang SS; Liao DF
Clin Exp Pharmacol Physiol; 2007; 34(5-6):450-6. PubMed ID: 17439414
[TBL] [Abstract][Full Text] [Related]
9. β-elemene acts as an antitumor factor and downregulates the expression of survivin, Bcl-xL and Mta-1.
Chen X; Wang Y; Luo H; Luo Z; Zhang T; Yang N; Long X; Xie H; Qiu W; Zhang B; Ding J; Yang L
Mol Med Rep; 2012 Nov; 6(5):989-95. PubMed ID: 22895653
[TBL] [Abstract][Full Text] [Related]
10. MLN4924 Synergistically Enhances Cisplatin-induced Cytotoxicity via JNK and Bcl-xL Pathways in Human Urothelial Carcinoma.
Ho IL; Kuo KL; Liu SH; Chang HC; Hsieh JT; Wu JT; Chiang CK; Lin WC; Tsai YC; Chou CT; Hsu CH; Pu YS; Shi CS; Huang KH
Sci Rep; 2015 Nov; 5():16948. PubMed ID: 26592553
[TBL] [Abstract][Full Text] [Related]
11. CCN2 enhances resistance to cisplatin-mediating cell apoptosis in human osteosarcoma.
Tsai HC; Huang CY; Su HL; Tang CH
PLoS One; 2014; 9(3):e90159. PubMed ID: 24637722
[TBL] [Abstract][Full Text] [Related]
12. Survivin knockdown enhances gastric cancer cell sensitivity to radiation and chemotherapy in vitro and in nude mice.
Shen X; Zheng JY; Shi H; Zhang Z; Wang WZ
Am J Med Sci; 2012 Jul; 344(1):52-8. PubMed ID: 22261621
[TBL] [Abstract][Full Text] [Related]
13. Systemic delivery of siRNA specific to tumor mediated by atelocollagen: combined therapy using siRNA targeting Bcl-xL and cisplatin against prostate cancer.
Mu P; Nagahara S; Makita N; Tarumi Y; Kadomatsu K; Takei Y
Int J Cancer; 2009 Dec; 125(12):2978-90. PubMed ID: 19422046
[TBL] [Abstract][Full Text] [Related]
14. Beyond cell death - antiapoptotic Bcl-2 proteins regulate migration and invasion of colorectal cancer cells in vitro.
Koehler BC; Scherr AL; Lorenz S; Urbanik T; Kautz N; Elssner C; Welte S; Bermejo JL; Jäger D; Schulze-Bergkamen H
PLoS One; 2013; 8(10):e76446. PubMed ID: 24098503
[TBL] [Abstract][Full Text] [Related]
15. Knockdown of Bcl-xL enhances growth-inhibiting and apoptosis-inducing effects of resveratrol and clofarabine in malignant mesothelioma H-2452 cells.
Lee YJ; Hwang IS; Lee YJ; Lee CH; Kim SH; Nam HS; Choi YJ; Lee SH
J Korean Med Sci; 2014 Nov; 29(11):1464-72. PubMed ID: 25408576
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of antiapoptotic genes in breast cancer cells by siRNA loaded into hybrid nanoparticles.
de Mello LJ; Souza GR; Winter E; Silva AH; Pittella F; Creczynski-Pasa TB
Nanotechnology; 2017 Apr; 28(17):175101. PubMed ID: 28230534
[TBL] [Abstract][Full Text] [Related]
17. Repression of GRIM19 expression potentiates cisplatin chemoresistance in advanced bladder cancer cells via disrupting ubiquitination-mediated Bcl-xL degradation.
Ni F; Yan CY; Zhou S; Hui PY; Du YH; Zheng L; Yu J; Hu XJ; Zhang ZG
Cancer Chemother Pharmacol; 2018 Oct; 82(4):593-605. PubMed ID: 30032449
[TBL] [Abstract][Full Text] [Related]
18. Survivin inhibitor YM155 induces mitochondrial dysfunction, autophagy, DNA damage and apoptosis in Bcl-xL silenced glioma cell lines.
Jane EP; Premkumar DR; Sutera PA; Cavaleri JM; Pollack IF
Mol Carcinog; 2017 Apr; 56(4):1251-1265. PubMed ID: 27805285
[TBL] [Abstract][Full Text] [Related]
19. Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study.
Kuo KL; Liu SH; Lin WC; Hsu FS; Chow PM; Chang YW; Yang SP; Shi CS; Hsu CH; Liao SM; Chang HC; Huang KH
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262032
[TBL] [Abstract][Full Text] [Related]
20. The role of RhoC in ovarian epithelial carcinoma: a marker for carcinogenesis, progression, prognosis, and target therapy.
Zhao Y; Zheng HC; Chen S; Gou WF; Xiao LJ; Niu ZF
Gynecol Oncol; 2013 Sep; 130(3):570-8. PubMed ID: 23764197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
